TOMAS-2

v 3.0

26-NOV-2020



Phase 2 randomized trial of trabectedin + olaparib vs. trabectedin in advanced, metastatic or unresectable soft tissue sarcoma after failure of standard treatments.


Forgot password?

SOFT LOCK is activated, data can be shown but not updated


Supported browsers:
Chrome v.75 or superior
Firefox v.57 or superior
Other browsers are not supported.